KD Pharma Bexbach GmbH

KD Pharma Bexbach GmbH is one of the leading manufacturers of highly-purified omega-3 fatty acids, which are used as an active ingredient in medicinal products and an ingredient in dietary supplements. KD Pharma has a unique, patented production technology which allows it to manufacture particularly high concentrations of omega-3 fatty acids up to a purity level of 99%. Before being acquired by capiton, the company was at the limit of its capacity owing to lack of investment, and needed fresh capital to enable it to process major new orders from the pharmaceutical sector. capiton not only acquired a majority stake in KD Pharma, but also invested a significant amount in expanding production facilities in order to increase capacity several-fold, and therefore to meet market demand. KD Pharma today has the most efficient and advanced production operation in its field; it has significant capacity and has become a market leader and partner to large pharmaceutical corporations. Since the entrance of capiton in 2013, turnover and profit have increased significantly.

 

The founder of KD Pharma, Dr Krumbholz, retired from the Board of Directors shortly after the acquisition, though he remained involved as an advisor and shareholder. Mr Groet, an experienced manager, was appointed at the time as CEO and partner. He has made a significant contribution to the success of the company, and has developed KD Pharma to become an international operation.

KD Pharma Bexbach GmbH

Investment: current
Industry: Health Care / Life Science
Financing Events: Growth

www.kd-pharma.com